| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.642 | 6.069 | 3.471 | 4.179 | 3.644 | 4.118 | 3.615 |
| Total Income - EUR | - | - | - | 4.642 | 6.069 | 3.471 | 4.179 | 3.644 | 4.118 | 3.615 |
| Total Expenses - EUR | - | - | - | 1.052 | 1.602 | 1.223 | 316 | 749 | 643 | 88 |
| Gross Profit/Loss - EUR | - | - | - | 3.590 | 4.467 | 2.248 | 3.863 | 2.895 | 3.475 | 3.527 |
| Net Profit/Loss - EUR | - | - | - | 3.451 | 4.285 | 2.150 | 3.738 | 2.785 | 2.878 | 2.975 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Epyhealth S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 3.540 | 4.372 | 6.440 | 10.018 | 12.834 | 3.016 | 3.191 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | 3.540 | 4.372 | 6.440 | 10.018 | 12.834 | 3.016 | 3.191 |
| Shareholders Funds | - | - | - | 3.494 | 4.327 | 6.395 | 9.991 | 12.807 | 2.919 | 3.015 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 46 | 46 | 45 | 27 | 27 | 98 | 177 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Epyhealth S.r.l.